Samsara BioCapital, 10% Owner: Kalaris Therapeutics KLRS Buy · Filed 02/17

Trade details

Type: Insider buy
Amount: $5,000,005.74
Shares · price: 479,847 sh · $10.42 a share
Held after: 1,979,847 sh
Stock: Kalaris Therapeutics KLRS
Person: Samsara BioCapital10% Owner
Trade date: 25/12/18
Filed: 26/02/17
Days to filing: 61 days

First buy since 2023

Insiders buying this week: 5 insiders
Holding change: +32.0%

Kalaris Therapeutics trades, last 26 weeks

What else happened in Kalaris Therapeutics around then

Filed or reported within 30 days of the trade day · 25/11/18~01/17

Samsara BioCapital's recent trades

Samsara BioCapital10% Owner
BuyKalaris Therapeutics
Buy
Kalaris Therapeutics
KLRS
$1.2M
244,300 sh
$1.2M
Filed 05/22
Traded 05/20
Samsara BioCapital10% Owner
BuyMineralys Therapeutics
Buy
Mineralys Therapeutics
MLYS
$8.1M
600,000 sh
$8.1M
Filed 25/03/17
Traded 25/03/13
Samsara BioCapital10% Owner
BuyNeurogene
Buy
Neurogene
NGNE
$516.8K
20,748 sh
$516.8K
Filed 24/11/27
Traded 24/11/26
Samsara BioCapital10% Owner
BuyNeurogene
Buy
Neurogene
NGNE
$406.8K
15,219 sh
$406.8K
Filed 24/11/27
Traded 24/11/26
Samsara BioCapital10% Owner
BuyNeurogene
Buy
Neurogene
NGNE
$281K
10,803 sh
$281K
Filed 24/11/27
Traded 24/11/26